Sutro Biopharma (STRO) Competitor Comparison
We are evaluating the key criteria listed to compare Sutro Biopharma (STRO) against its competitors in the Biotechnology industry.
Market Capitalization
195 / 368Gross Profits
0 / 278Total Revenue
124 / 300EBITDA
269 / 337Free Cashflow
265 / 352Quick Ratio
185 / 357Earnings per Share
200 / 359Dividend yield
0 / 6Total Cash
88 / 358Performance 3 years
246 / 368Performance 5 years
197 / 368Performance 10 years
186 / 368Linearity 3 years
236 / 368Linearity 5 years
104 / 368Linearity 10 years
126 / 368Total Rank
270 / 368Dividend Rank
279 / 368Valuation Rank
233 / 368Piotroski Rank
36 / 368Muliplier Rank
55 / 368Muliplier Rank - STRO ranking 55 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.